Hydroxyzine Can Worsen Parkinson's Disease Symptoms
Hydroxyzine should be avoided in patients with Parkinson's disease due to its anticholinergic properties that can exacerbate parkinsonian symptoms. 1
Mechanism of Concern
- Hydroxyzine is a first-generation antihistamine with significant anticholinergic properties 1
- Anticholinergic medications can induce or worsen symptoms of Parkinson's disease, including:
Impact on Parkinson's Disease
- Antidopaminergic agents, including those with anticholinergic properties like hydroxyzine, can induce symptoms resembling Parkinson's disease, including bradykinesia, tremors, and rigidity 1
- The anticholinergic burden in Parkinson's disease patients is significant and can worsen both motor and non-motor symptoms 2
- Anticholinergic medications can counteract the therapeutic effects of medications used to treat Parkinson's disease, particularly cholinesterase inhibitors that may be prescribed for cognitive symptoms 2
Clinical Considerations
First-generation antihistamines like hydroxyzine are associated with:
Older adults, including many Parkinson's patients, are more sensitive to psychomotor impairment from first-generation antihistamines and have increased risk for complications such as falls 1
Alternative Options
If antihistamine therapy is necessary for a patient with Parkinson's disease:
For sleep issues in Parkinson's patients (which hydroxyzine is sometimes prescribed for):
Common Pitfalls to Avoid
- Assuming that hydroxyzine's sedative properties make it a good choice for sleep in Parkinson's patients - the anticholinergic burden outweighs potential benefits 1
- Overlooking that anticholinergic medications contribute significantly to cognitive decline in Parkinson's patients 2
- Failing to recognize that medications used for non-motor symptoms (like hydroxyzine for anxiety or sleep) can worsen motor symptoms of Parkinson's disease 2